As previously mentioned, siRNA silencing of RECQL1 has been shown to kill various HCC, ovarian cancer cell lines, and hypopharyngeal carcinoma and have in vivo activity in mice (Futami et al., 2010; Arai et al., 2011; Sanada et al., 2013). Here, RECQL is linked to hypopharyngeal carcinoma.